
We are a young team of biologists based at Maastricht University and embedded within both cardiovascular and neuroscience research institutes. We are fascinated by the cerebral microcirculation and the complex interplay between endothelial cells and surrounding – mainly glial – cells. We carry experimental work ranging from cell experiments to behavioural and in vivo imaging studies. We aim to reveal key pathophysiological mechanisms affecting the glio-vascular unit in cerebral Small Vessel Disease. We hope that our findings will provide new insights for the prevention and treatment of vascular dementia.

Dementia is the late clinical manifestation of a disease that often progresses silently for decades before crucial locomotor, behavioural and cognitive processes are being affected. Beyond Alzheimer’s disease, many neurodegenerative disorders can lead to dementia and dementia is therefore referred as an “umbrella” term. In fact, when dementia originates from cerebrovascular defects, it is classified as vascular dementia – which is the end stage of the underlying so-called vascular cognitive impairment. Our research group studies cerebral small vessel disease (cSVD), the most prevalent form of vascular cognitive impairment and dementia (VCID).
“You are as young as your blood vessels“
Vascular health is especially relevant for brain function due to the very high density of cerebral blood vessels. This dense and complex vascular network is of major importance for the brain that has a very high energy demand. These cerebral small vessels exhibit special features e.g. to protect the brain (blood brain barrier) and to match cerebral blood flow to local neuronal activity (neurovascular coupling). Upon exposure to chronic cardiovascular risk factors however, such as hypertension and diabetes, the cerebral small vessels are getting damaged, progressively losing their structural and functional integrity. This results into a series of deleterious events such as an increased BBB permeability leading to neuroinflammation but also neurovascular uncoupling leading to local hypoxic injuries.
“We can’t fix what we don’t know”
There has been a tremendous progression in the field to understand the pathophysiological mechanisms of cerebral small vessel disease and other VCID pathologies. This is thanks to the integration of several disciplines, a new generation of researchers trained across fields and the awareness of public authorities of the major financial and societal problem caused by dementia. At the same time, while the field is progressing, well supported by new technological means, we dive into the cellular and molecular complexity that are inherent to organisms with millions of years of evolution. We start realising that every cell, previously thought to execute a certain range of functions relevant for a defined cell type, is capable of other specialised functions that may even change from one to another brain area due to diverse environmental cues.
“Glia, more than just brain glue”
Allen & Barres, Nature 2009
Glial cells are the most abundant cells in the brain and were believed for long time to only have a supporting role, gluing cells together. Glial biologists in the last decades have studied glial cell types and have revealed the beauty of glial cells and the diversity of their functions. In the past few years, further insights have been gained about the contribution of glial cells (astrocytes, microglia, oligodendrocyte precursor cells) to vascular homeostasis. In short, glial cells seem to interact with cerebral small vessels to help promoting and maintaining the blood brain barrier but also to regulate cerebral blood flow and repair damaged blood vessels. While lots of investigations remain to be carried to confirm, refine and deepen these findings, this creates plenty of opportunities to locally fix cerebral small vessels, making use of glial cells like swiss army knives.
Photo credit: Cajal Institute, Cajal Legacy, Spanish National Research Council (CSIC), Madrid, Spain

Our research group aims to reveal key pathophysiological mechanisms affecting the glio-vascular unit in cerebral Small Vessel Disease. We hope that our findings will provide new insights for the prevention and treatment of vascular dementia.
“It’s a long journey but the mission worths it – just focus on the next step”
S. Foulquier


Sebastien Foulquier
Pharm.D, Ph.D.
Group leader
Assistant Professor

Sara Lambrichts
M.Sc., Ph.D. student
MHENS Institute
Cerebrovascular dysfunction in HFpEF

Melissa Colin
M.Sc., Ph.D. student
MHENS Institute
U. of Lorraine
AT1 receptor biased agonists in stroke

Laura van der Taelen
M.Sc., Ph.D. student
CARIM Institute/UAM
CSVD:
an inflammatory tangle

Elien Bollen
M.Sc., Ph.D. student
KU Leuven/CARIM Institute
Mechanobiology
in cSVD

Daria Majcher
M.Sc., Scientist
CARIM Institute
Oligovascular interaction: relevance in cSVD

Ellen Weltjens
B.Sc., Lab manager
CARIM Institute
Cell culture and live cell imaging expert

Eline Berends
Ph.D. in October 2024
Now:
Post-doc KI, Sweden
AGE-ing of the brain microcirculation

Narek Manukjan
Ph.D. in March 2024
Now:
Patent attorney trainee
White matter really matters in cSVD: role of hypoxia

Danielle Kerkhofs
M.D., Ph.D. in March 2024
Now:
Vascular neurologist
Inflammatory cells and BBB leakage in cSVD

Takashi Koizumi
M.D., Ph.D. in August 2018
Now:
Vascular neurologist
Genetic and neuroinflammatory components of cSVD









Full bibliography in NCBI
Flagship publications:











Maastricht is the southern largest city from The Netherlands and benefits from a very international exposure.
If you’d like to join our team, please contact us to discuss opportunities.
Internships: we host 1-2 master students every year for 8-10 months internships. Please reach out!
Give now to support our research!
Your donation will be used to support the high costs of lab reagents but also to support members of our team to to communicate their findings at national and international scientific conferences.
Please make your donation via the –> Universiteitsfonds Limburg
Choose Project “Algemeen” (General) and indicate “The GlioVasc Lab” in the text box.
Having trouble donating online?
You can also transfer your donation to account number NL21 INGB 0653 6632 42 (Stichting Universiteitsfonds Limburg/ SWOL) stating your initials and last name. Don’t forget to indicate “The GlioVasc Lab” as communication to support our research efforts!
Maastricht University
Dept of Pharmacology and Toxicology
Universiteitssingel 50
P.O. Box 616
6229 ER Maastricht